Impact of SARSCoV2 on Allogeneic Stem Cell Transplantation Organization : a French Experience
Conditions: Allogeneic Stem Cell Transplantation; SARS-CoV2 Infection Intervention: Sponsor: Central Hospital, Nancy, France Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: France Health | Hospitals | Research | SARS | Stem Cell Therapy | Stem Cells | Transplants